Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - September 2003

  1. One on One. Can I Get Whooping Cough Even If I Was Vaccinated As a Child? Mayo Clin Womens Healthsource.  4 (10): 8; October 2000.

  2. Update: Adverse Events Following Civilian Smallpox Vaccination--United States, 2003. MMWR Morb.Mortal.Wkly.Rep.  52 (34): 819-820; August 29, 2003.

  3. Vaccination Services in Postwar Iraq, May 2003. MMWR Morb.Mortal.Wkly.Rep.  52 (31): 734-735; August 8, 2003.

  4. National, State, and Urban Area Vaccination Levels Among Children Aged 19-35 Months--United States, 2002. MMWR Morb.Mortal.Wkly.Rep.  52 (31): 728-732; August 8, 2003.

  5. Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb.Mortal.Wkly.Rep.  52 (31): 739-740; August 8, 2003.

  6. Vaccination Coverage Among Children Entering School--United States, 2002-03 School Year. MMWR Morb.Mortal.Wkly.Rep.  52 (33): 791-793; August 22, 2003.

  7. Vaccination Coverage Levels Among Alaska Native Children Aged 19-35 Months--National Immunization Survey, United States, 2000-2001. MMWR Morb.Mortal.Wkly.Rep.  52 (30): 710-713; August 1, 2003.

  8. Aaby, P.; Jensen, H.; Simondon, F.; Whittle, H.  High-Titer Measles Vaccination Before 9 Months of Age and Increased Female Mortality: Do We Have an Explanation? Semin Pediatr Infect Dis.  14 (3): 220-232; July 2003.

  9. Aragon, T. J.; Ulrich, S.; Fernyak, S. E.; Rutherford, G. W.  Risks of Serious Complications and Death From Smallpox Vaccination: A Systematic Review of the United States Experience, 1963-1968. BMC Public Health.  3 (1): 26; August 11, 2003.

  10. Atlas, R. M.; Clover, R.  Commentary on Implications of the 1971 Outbreak in Aralsk, Kazakhstan, for U.S. Smallpox Vaccination Policy (No. 1). Crit Rev Microbiol.  29 (2): 159-161; 2003.

  11. Ault, A.  US Advisory Panel Urges Government to Subsidise Vaccine Costs. Recommendations Would Increase Vaccination Rates and Stimulate Research and Development. Lancet.  362 (9383): 539; August 16, 2003.

  12. Bauch, C. T.; Galvani, A. P.; Earn, D. J.  Group Interest Versus Self-Interest in Smallpox Vaccination Policy. Proc Natl Acad Sci U S A. 100(18): 10564-10567, September 2, 2003.

  13. Bearman, G.; Fuentes, L.; Van Vorenkamp, J. L.; Drusin, L. M.  Vaccination Without Documentation: Influenza Immunization Among Medical Residents at a Tertiary-Care Medical Center. Infect Control Hosp.Epidemiol.  24 (8): 626-628; August 2003.

  14. Begue, P.  [Vaccination in France]. Arch Pediatr.  10 (6): 571-578; June, 2003.

  15. Bothamley, G. H.; Cooper, E.; Shingadia, D.; Mellanby, A.  Tuberculin Testing Before BCG Vaccination. BMJ.  327 (7409): 243-244; August 2, 2003.

  16. Butler, D.  WHO Prepares for Final Push to Rid the World of Polio. Nature.  424 (6949): 604; August 7, 2003.

  17. Charatan, F.  US Panel Advises Caution Over Smallpox Vaccination. BMJ.  327 (7412): 414; August 23, 2003.

  18. D'Amelio, R.; Biselli, R.; Natalicchio, S.; Lista, F.; Peragallo, M. S.  Vaccination Programmes in the Italian Military. Vaccine.  21 (25-26): 3530-3533; September 8, 2003.

  19. Deem, M. W.; Lee, H. Y.  Sequence Space Localization in the Immune System Response to Vaccination and Disease. Phys.Rev Lett.  91 (6): 068101; August 8, 2003.

  20. DeStefano, F.; Thompson, W. W.  MMR Vaccination and Autism: Is There a Link? Expert.Opin.Drug Saf.  1 (2): 115-120; July, 2002.

  21. Egede, L. E.  Association Between Number of Physician Visits and Influenza Vaccination Coverage Among Diabetic Adults With Access to Care. Diabetes Care.  26 (9): 2562-2567; September, 2003.

  22. Farrington, C. P.; Kanaan, M. N.; Gay, N. J.  Branching Process Models for Surveillance of Infectious Diseases Controlled by Mass Vaccination. Biostatistics.  4 (2): 279-295; April, 2003.

  23. Fedson, D. S.  Pneumococcal Vaccination in Older Adults. N.Engl.J Med.  349 (7): 712-714; August 14, 2003.

  24. Foxwell, A. R.; Cripps, A. W.; Dear, K. B.  Haemophilus Influenzae Oral Whole Cell Vaccination for Preventing Acute Exacerbations of Chronic Bronchitis. Cochrane Database Syst Rev.3): CD001958; 2003.

  25. Ghebrehewet, S.; Falconer, M.; McDonald, P.; Schlecht, B.  MMR Vaccine Uptake Rates: A Data Validation Study. Commun Dis Public Health.  6 (2): 144-146; June, 2003.

  26. Ghosh, T. K.  Controversies in Rabies Vaccination. Indian J Pediatr.  70 (6): 495-498; June, 2003.

  27. Hak, E.; Bonten, M. J.; Hoes, A. W.  Pneumococcal Vaccination in Older Adults. N.Engl.J Med.  349 (7): 712-714; August 14, 2003.

  28. Hammarlund, E.; Lewis, M. W.; Hansen, S. G.; Strelow, L. I.; Nelson, J. A.; Sexton, G. J.; Hanifin, J. M.; Slifka, M. K.  Duration of Antiviral Immunity After Smallpox Vaccination. Nat.Med.  9 (9): 1131-1137; September, 2003.

  29. Hanna, J. N.; Bullen, R. C.; Ziegler, C. L.; Akee, T.; Dostie, B. G.; Lort-Phillips, K.  An Assessment of the Implementation of the Pneumococcal Conjugate Vaccination Program for Aboriginal and Torres Strait Infants in North Queensland. Commun Dis Intell.  27 (2): 262-266; 2003.

  30. Hanslik, T.; Boelle, P. Y.; Schwarzinger, M.; Carrat, F.; Freedberg, K. A.; Valleron, A. J.; Flahault, A.  Varicella in French Adolescents and Adults: Individual Risk Assessment and Cost-Effectiveness of Routine Vaccination. Vaccine.  21 (25-26): 3614-3622; September 8, 2003.

  31. Hirschmann, J. V.  Pneumococcal Vaccination in Older Adults. N.Engl.J Med.  349 (7): 712-714; August 14, 2003.

  32. Hsu, H. C.; Lin, R. S.; Tung, T. H.; Chen, T. H.  Cost-Benefit Analysis of Routine Childhood Vaccination Against Chickenpox in Taiwan: Decision From Different Perspectives. Vaccine.  21 (25-26): 3982-3987; September 8, 2003.

  33. Isik, N.; Uzel, N.; Gokcay, G.; Kilic, A.; Yilmaz, G.; Sadikoglu, B.; Diri, S.  Seroconversion After Measles Vaccination at Nine and Fifteen Months of Age. Pediatr Infect Dis J.  22 (8): 691-695; August 2003.

  34. Jansen, V. A.; Stollenwerk, N.; Jensen, H. J.; Ramsay, M. E.; Edmunds, W. J.; Rhodes, C. J.  Measles Outbreaks in a Population With Declining Vaccine Uptake. Science.  301 (5634): 804; August 8, 2003.

  35. Jimenez, R.; Larrauri, A.; Carrasco, P.; Esteban, J.; Gomez-Lopez, L. I.; Gil, A.  Influenza Coverages in Spain and Vaccination-Related Factors in the Subgroup Aged 50-64 Years. Vaccine.  21 (25-26): 3550-3555; September 8, 2003.

  36. Jungbauer-Gans, M.; Kriwy, P.  [Influence Exercised by Physicians on the Vaccination Rate]. Gesundheitswesen.  65 (7): 464-470; July 2003.

  37. Kassianos, G.  Influenza Vaccination of Patients Receiving Cytotoxic Chemotherapy: Can We Do Better? Int J Clin Pract.  57 (6): 457-458; July 2003.

  38. Korobeinikov, A.; Maini, P. K.; Walker, W. J.  Estimation of Effective Vaccination Rate: Pertussis in New Zealand As a Case Study. J Theor.Biol.  224 (2): 269-275; September 21, 2003.

  39. Lane, J. M.; Goldstein, J.  Adverse Events Occurring After Smallpox Vaccination. Semin Pediatr Infect Dis.  14 (3): 189-195; July 2003.

  40. Leggat, P. A.  The Traveller's Pocket Medical Guide and International Certificate of Vaccination. J Travel.Med.  10 (4): 251; July 2003.

  41. Lloyd, J. C.; Haber, P.; Mootrey, G. T.; Braun, M. M.; Rhodes, P. H.; Chen, R. T.  Adverse Event Reporting Rates Following Tetanus-Diphtheria and Tetanus Toxoid Vaccinations: Data From the Vaccine Adverse Event Reporting System (VAERS), 1991-1997. Vaccine.  21 (25-26): 3746-3750; September 8, 2003.

  42. Lucas, A. H.; McLean, G. R.; Reason, D. C.; O'Connor, A. P.; Felton, M. C.; Moulton, K. D.  Molecular Ontogeny of the Human Antibody Repertoire to the Haemophilus Influenzae Type b Polysaccharide: Expression of Canonical Variable Regions and Their Variants in Vaccinated Infants.  Clin Immunol.  108 (2): 119-127; August 2003.

  43. Marras, T. K.  Pneumococcal Vaccination in Older Adults. N.Engl.J Med.  349 (7): 712-714; August 14, 2003.

  44. Minor, P. D.  Polio Vaccines and the Cessation of Vaccination. Expert.Rev Vaccines.  2 (1): 99-104; February, 2003.

  45. Moverare, R.  Immunological Mechanisms of Specific Immunotherapy With Pollen Vaccines: Implications for Diagnostics and the Development of Improved Vaccination Strategies. Expert.Rev Vaccines.  2 (1): 85-97; February, 2003.

  46. Nardelli-Haefliger, D.; Wirthner, D.; Schiller, J. T.; Lowy, D. R.; Hildesheim, A.; Ponci, F.; De Grandi, P.  Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles. J Natl Cancer Inst.  95 (15): 1128-1137; August 6, 2003.

  47. Raufu, A.  Polio Vaccine Plans May Run into Problems in Nigeria. BMJ.  327 (7410): 380; August 9, 2003.

  48. Ring, A.; Marx, G.; Steer, C.; Prendiville, J.; Ellis, P.  Poor Uptake of Influenza Vaccinations in Patients Receiving Cytotoxic Chemotherapy. Int J Clin Pract.  57 (6): 542-543; July 2003.

  49. Samoilovich, E.; Roivainen, M.; Titov, L. P.; Hovi, T.  Serotype-Specific Mucosal Immune Response and Subsequent Poliovirus Replication in Vaccinated Children. J Med Virol.  71 (2): 274-280; October, 2003.

  50. Schroeder, B. M.  ACIP Issues Guidelines on the Use of Smallpox Vaccine in a Pre-Event Vaccination Program. Am Fam.Physician.  68 (3): 554, 557-554, 558; August 1, 2003.

  51. Skledar, S. J.; Hess, M. M.; Ervin, K. A.; Gross, P. R.; Nowalk, M. P.; Carter, H.; Zimmerman, R. K.; Middleton, D.  Designing a Hospital-Based Pneumococcal Vaccination Program. Am J Health Syst Pharm.  60 (14): 1471-1476; July 15, 2003.

  52. Thirlaway, K.; Lukman, H.  Meningitis C Vaccine Uptake by British Undergraduates. Commun Dis Public Health.  6 (2): 157-160; June, 2003.

  53. Tieman, J.  Vaccination Solutions. IOM Suggests Providers Be Reimbursed. Mod.Healthc.  33 (32): 12-13; August 11, 2003.

  54. Trzonkowski, P.; Mysliwska, J.; Szmit, E.; Wieckiewicz, J.; Lukaszuk, K.; Brydak, L. B.; Machala, M.; Mysliwski, A.  Association Between Cytomegalovirus Infection, Enhanced Proinflammatory Response and Low Level of Anti-Hemagglutinins During the Anti-Influenza Vaccination-an Impact of Immunosenescence. Vaccine.  21 (25-26): 3826-3836; September 8, 2003.

  55. Vedhara, K.; Bennett, P. D.; Clark, S.; Lightman, S. L.; Shaw, S.; Perks, P.; Hunt, M. A.; Philip, J. M.; Tallon, D.; Murphy, P. J.; Jones, R. W.; Wilcock, G. K.; Shanks, N. M.  Enhancement of Antibody Responses to Influenza Vaccination in the Elderly Following a Cognitive-Behavioural Stress Management Intervention. Psychother.Psychosom.  72 (5): 245-252; September, 2003.

  56. Verstraeten, T.; Jumaan, A. O.; Mullooly, J. P.; Seward, J. F.; Izurieta, H. S.; DeStefano, F.; Black, S. B.; Chen, R. T.  A Retrospective Cohort Study of the Association of Varicella Vaccine Failure With Asthma, Steroid Use, Age at Vaccination, and Measles-Mumps-Rubella Vaccination. Pediatrics.  112 (2): e98-103; August 2003.

  57. Vines, J.  [An Appraisal of the Pros and Cons of Mass Vaccination]. An Sist.Sanit.Navar.  20 (3): 391-394; September, 1997.

  58. von Herrath, M. G.  Vaccination to Prevent Type 1 Diabetes. Expert.Rev Vaccines.  1 (1): 25-28; June, 2002.

  59. Wongsurakiat, P.; Lertakyamanee, J.; Maranetra, K. N.; Jongriratanakul, S.; Sangkaew, S.  Economic Evaluation of Influenza Vaccination in Thai Chronic Obstructive Pulmonary Disease Patients. J Med Assoc Thai.  86 (6): 497-508; June, 2003.

Back to Top